Literature DB >> 1991842

Influence of age on the metabolism of plasma low density lipoproteins in healthy males.

S Ericsson1, M Eriksson, S Vitols, K Einarsson, L Berglund, B Angelin.   

Abstract

The plasma concentration of the atherogenic low density lipoproteins (LDL) increases with age. To clarify the mechanism of this change, we studied the kinetics of autologous 125I-LDL apolipoprotein B (apo B) in 41 normolipidemic, nonobese healthy males. For comparison, they were divided into three age groups: young, 21-39 yr (n = 18), middle-aged, 40-59 yr (n = 11), and old, 60-80 yr (n = 12). The levels of plasma LDL cholesterol and LDL apo B increased from respectively 3.4 +/- 0.1 (SEM) mmol/liter and 86 +/- 2 mg/dl in the young to 4.1 +/- 0.1 mmol/liter and 95 +/- 3 mg/dl in the old (P less than 0.01), and this increase was linked to a progressively decreased (r = -0.38, P less than 0.02) fractional catabolic rate of LDL apo B (0.348 +/- 0.010 pools per day in the young vs. 0.296 +/- 0.009 pools per day in the old, P less than 0.01). The production rate of LDL apo B did not differ significantly between the groups. The reduced fractional catabolic rate of LDL apo B in the old was not associated with a decrease in binding affinity of the LDL particle to its receptor, as judged from its ability to compete for 125I-LDL fibroblast binding. When hepatic LDL receptor expression was stimulated by cholestyramine treatment in six old males, their LDL apo B fractional catabolic rate increased to the levels observed in the young subjects. We conclude that the increase in LDL which normally occurs with age is explained by a reduced capacity for its removal, and hypothesize that this is mediated via a reduced hepatic LDL receptor expression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991842      PMCID: PMC296347          DOI: 10.1172/JCI115034

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Lipoprotein fractionation.

Authors:  K Carlson
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1973

Review 2.  Lipoprotein receptors and cholesterol homeostasis.

Authors:  R W Mahley; T L Innerarity
Journal:  Biochim Biophys Acta       Date:  1983-05-24

Review 3.  Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.

Authors:  M S Brown; J L Goldstein
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

4.  Joint distribution of lipoprotein cholesterol classes. The Framingham study.

Authors:  R D Abbott; R J Garrison; P W Wilson; F H Epstein; W P Castelli; M Feinleib; C LaRue
Journal:  Arteriosclerosis       Date:  1983 May-Jun

5.  Effect of donor age on the binding and degradation of low density lipoproteins by cultured human arterial smooth muscle cells.

Authors:  E L Bierman; J J Albers; A Chait
Journal:  J Gerontol       Date:  1979-07

6.  Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment.

Authors:  J Ahlberg; B Angelin; K Einarsson
Journal:  J Lipid Res       Date:  1981-03       Impact factor: 5.922

7.  Cholestyramine-induced changes in low density lipoprotein composition and metabolism. I. Studies in the guinea pig.

Authors:  J L Witztum; S G Young; R L Elam; T E Carew; M Fisher
Journal:  J Lipid Res       Date:  1985-01       Impact factor: 5.922

Review 8.  Mechanisms of primary hypercholesterolemia in humans.

Authors:  G L Vega; S M Grundy
Journal:  Am Heart J       Date:  1987-02       Impact factor: 4.749

9.  Low-density lipoprotein metabolism in cerebrotendinous xanthomatosis.

Authors:  C M Ballantyne; G L Vega; C East; G Richards; S M Grundy
Journal:  Metabolism       Date:  1987-03       Impact factor: 8.694

10.  Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors.

Authors:  R W Mahley; D Y Hui; T L Innerarity; K H Weisgraber
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

View more
  30 in total

Review 1.  Fatty acid composition of the diet: impact on serum lipids and atherosclerosis.

Authors:  N Zöllner; F Tatò
Journal:  Clin Investig       Date:  1992-11

2.  Fenofibrate Reduces Age-related Hypercholesterolemia in Normal Rats on a Standard Diet.

Authors:  Ying Han; Mi-Hyang Do; Mi Sun Kim; Eunhui Seo; Mi-Kyoung Park; Duk Kyu Kim; Hye-Jeong Lee; Su-Yeong Seo
Journal:  Korean J Physiol Pharmacol       Date:  2010-04-30       Impact factor: 2.016

3.  Maternal dyslipidemia during early pregnancy and epigenetic ageing of the placenta.

Authors:  Deepika Shrestha; Tsegaselassie Workalemahu; Fasil Tekola-Ayele
Journal:  Epigenetics       Date:  2019-06-14       Impact factor: 4.528

4.  Post-genome-wide association study challenges for lipid traits: describing age as a modifier of gene-lipid associations in the Population Architecture using Genomics and Epidemiology (PAGE) study.

Authors:  Logan Dumitrescu; Cara L Carty; Nora Franceschini; Lucia A Hindorff; Shelley A Cole; Petra Bůžková; Fredrick R Schumacher; Charles B Eaton; Robert J Goodloe; David J Duggan; Jeff Haessler; Barbara Cochran; Brian E Henderson; Iona Cheng; Karen C Johnson; Chris S Carlson; Shelly-Ann Love; Kristin Brown-Gentry; Alejandro Q Nato; Miguel Quibrera; Garnet Anderson; Ralph V Shohet; José Luis Ambite; Lynne R Wilkens; Loïc Le Marchand; Christopher A Haiman; Steven Buyske; Charles Kooperberg; Kari E North; Myriam Fornage; Dana C Crawford
Journal:  Ann Hum Genet       Date:  2013-06-28       Impact factor: 1.670

5.  Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy.

Authors:  José Miranda-Bautista; Celia de Gracia-Fernández; María López-Ibáñez; María Barrientos; Alejandra Gallo-Moltó; Marina González-Arias; Casilda González-Gil; Alicia Díaz-Redondo; Ignacio Marín-Jiménez; Luis Menchén
Journal:  Dig Dis Sci       Date:  2015-02-14       Impact factor: 3.199

Review 6.  Nonalcoholic fatty liver disease and aging: epidemiology to management.

Authors:  Marco Bertolotti; Amedeo Lonardo; Chiara Mussi; Enrica Baldelli; Elisa Pellegrini; Stefano Ballestri; Dante Romagnoli; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

7.  Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study.

Authors:  Marco Bertolotti; Carlotta Franchi; Marco B L Rocchi; Andrea Miceli; M Vittoria Libbra; Alessandro Nobili; Giulia Lancellotti; Lucia Carulli; Chiara Mussi
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

Review 8.  Drug Therapy of Dyslipidemia in the Elderly.

Authors:  Srikanth Yandrapalli; Shashvat Gupta; Gabriela Andries; Howard A Cooper; Wilbert S Aronow
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

9.  Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol.

Authors:  Moumita Ghosh; Cecilia Gälman; Mats Rudling; Bo Angelin
Journal:  J Lipid Res       Date:  2014-12-22       Impact factor: 5.922

10.  Diet and age interactions with regards to cholesterol regulation and brain pathogenesis.

Authors:  Romina M Uranga; Jeffrey N Keller
Journal:  Curr Gerontol Geriatr Res       Date:  2010-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.